Enzymatica AB (FRA:EN9) Cyclically Adjusted Book per Share: €0.07 (As of Mar. 2026)


FRA:EN9 Enzymatica AB FRA:EN9
36 GF Score
Price €0.20
GF Value €0.16
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Enzymatica AB Cyclically Adjusted Book per Share?

Enzymatica AB FRA:EN9 +3.17% 36 Cyclically Adjusted Book per Share is €0.07 as of Mar. 2026. GuruFocus rates FRA:EN9 with a GF Score™ of 36/100 and a GF Value™ of €0.16 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Enzymatica AB's adjusted book value per share for the three months ended in Mar. 2026 was €0.042. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Enzymatica AB's average Cyclically Adjusted Book Growth Rate was -5.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -9.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Enzymatica AB was 5.70% per year. The lowest was -9.70% per year. And the median was -2.70% per year.

As of today (2026-07-06), Enzymatica AB's current stock price is €0.195. Enzymatica AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €0.07. Enzymatica AB's Cyclically Adjusted PB Ratio of today is 2.79.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Enzymatica AB was 18.07. The lowest was 1.39. And the median was 2.85.


Enzymatica AB  (FRA:EN9) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enzymatica AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.195/0.07
=2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Enzymatica AB was 18.07. The lowest was 1.39. And the median was 2.85.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Enzymatica AB Cyclically Adjusted Book per Share Related Terms


Enzymatica AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Enzymatica AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzymatica AB Cyclically Adjusted Book per Share Chart

Enzymatica AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.12 0.10 0.07 0.08

Enzymatica AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.07 0.08 0.07

FRA:EN9 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's Cyclically Adjusted PB Ratio falls into.


FRA:EN9
36GF Score
Enzymatica AB FRA:EN9
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enzymatica AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enzymatica AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.042/133.5600*133.5600
=0.042

Current CPI (Mar. 2026) = 133.5600.

Enzymatica AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.171 101.019 0.226
201609 0.165 101.138 0.218
201612 0.144 102.022 0.189
201703 0.136 102.022 0.178
201706 0.122 102.752 0.159
201709 0.121 103.279 0.156
201712 0.110 103.793 0.142
201803 0.099 103.962 0.127
201806 0.083 104.875 0.106
201809 0.072 105.679 0.091
201812 0.101 105.912 0.127
201903 0.091 105.886 0.115
201906 0.080 106.742 0.100
201909 0.076 107.214 0.095
201912 0.074 107.766 0.092
202003 0.071 106.563 0.089
202006 0.068 107.498 0.084
202009 0.067 107.635 0.083
202012 0.068 108.296 0.084
202103 0.063 108.360 0.078
202106 0.085 108.928 0.104
202109 0.082 110.338 0.099
202112 0.075 112.486 0.089
202203 0.063 114.825 0.073
202206 0.054 118.384 0.061
202209 0.008 122.296 0.009
202212 0.065 126.365 0.069
202303 0.056 127.042 0.059
202306 0.049 129.407 0.051
202309 0.044 130.224 0.045
202312 0.039 131.912 0.039
202403 0.040 132.205 0.040
202406 0.033 132.716 0.033
202409 0.069 132.304 0.070
202412 0.063 132.987 0.063
202503 0.059 132.825 0.059
202506 0.054 133.699 0.054
202509 0.051 133.480 0.051
202512 0.047 133.390 0.047
202603 0.042 133.560 0.042

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.07 mean?
Enzymatica AB (FRA:EN9) has a Cyclically Adjusted Book per Share of €0.07 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Enzymatica AB and its competitors.
Is Enzymatica AB's Cyclically Adjusted Book per Share too high?
Enzymatica AB's current Cyclically Adjusted Book per Share is €0.07. Overall, Enzymatica AB has a GF Score™ of 36/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Enzymatica AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Enzymatica AB's Cyclically Adjusted Book per Share of €0.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Enzymatica AB and its competitors. Enzymatica AB's current Cyclically Adjusted Book per Share is €0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzymatica AB stock overvalued right now?
Based on GuruFocus' analysis, Enzymatica AB (FRA:EN9) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.16, compared to a current price of €0.20 — trading 21.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is €0.07. Enzymatica AB's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Enzymatica AB (FRA:EN9), the current Cyclically Adjusted Book per Share is €0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enzymatica AB (FRA:EN9) Overvalued in 2026?

Based on GuruFocus' analysis, Enzymatica AB stock appears to be overvalued. The current stock price of €0.20 is trading 21.9% above its estimated GF Value™ of €0.16. GuruFocus considers Enzymatica AB to be Modestly Overvalued.

Key valuation signals for FRA:EN9:

  • Cyclically Adjusted Book per Share: €0.07
  • GF Value™: €0.16 vs. price of €0.20 (21.9% above fair value)
  • GF Score™: 36/100 with 2 warning signs

No single metric tells the full story. See the FRA:EN9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enzymatica AB Business Description

Other Exchanges ENZY:Sweden
Address Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
36GF Score

Get the complete analysis for FRA:EN9

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price
€0.16
GF Value